[ORGANIZATION]
Lancet Infectious Diseases
Featured in 2 tracked stories · first seen
Situations
Paxlovid efficacy trial for Long COVID
2 clusters · 7 sources · last updated
Latest: Paxlovid shows no significant benefit for Long Covid in large US study
A large-scale clinical trial conducted under the National Institutes of Health (NIH) RECOVER Initiative has found that extended courses of the antiviral drug Paxlovid do not significantly reduce Long COVID symptoms compa